-
Company Insights
Innovation and Patenting activity of WEX Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of WEX Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy Drug Details: Tetrodotoxin (TTX,...
-
Product Insights
Chemotherapy Induced Peripheral Neuropathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Drugs In Development, 2023’, provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Peripheral Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Neuropathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuropathy - Drugs In Development, 2023’, provides an overview of the Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Company Profile
WEX Inc – Company Profile
WEX Inc (WEX) is a technology-based company that offers corporate payment solutions. The company’s fleet solutions portfolio comprises a large fleet, small businesses, government fleets, and over a road card. It provides travel solutions, which consist of virtual travel payment solutions, virtual credit cards, and virtual payment solutions. WEX also offers fleet cards and fuel management, corporate cards, healthcare solutions such as medical claims solutions, employee health accounts, hospital payment solutions, and virtual insurance payment solutions. The company serves commercial...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tetrodotoxin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Tetrodotoxin Drug Details Tetrodotoxin (TTX, Tectin) is under development for the treatment of cancer...
-
Product Insights
Cancer Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cancer pain can be defined as a complex sensation that reflects both damages to the body and the body's response to the damage. Pain may arise due to tumor compressing or infiltrating tissue, from treatments and diagnostic procedures, or skin, nerve, and other changes caused by either the body's immune response or hormones released by the tumor. Cancer pain can be treated by analgesic drug therapy, non-opioid analgesics, opioid analgesics, adjuvant drugs, psychotherapy, anesthetic, and neurosurgical pain management. The Cancer...
-
Product Insights
Low Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Low Back Pain Pipeline Drugs Market Report Overview Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, injury, aging, arthritis, illness, and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such as NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants. Key Mechanism of Actions ·      Prostaglandin G/H Synthase...